AVEO Pharmaceuticals (AVEO) Shares Double on Novartis Deal
August 17, 2015 at 09:36 AM EDT
Shares of AVEO Pharmaceuticals Inc. (AVEO) were trading up +1.49 or +123.83 percent to $2.60 per share in Monday's premarket after the company announced a worldwide licensing agreement with Novartis (NVS) for the development and commercialization of the company's AV-380. AVEO stock closed at $1.17, unchanged in Friday's regular trading session. Founded as GenPath Pharmaceuticals ... READ MORE Read the rest of AVEO Pharmaceuticals (AVEO) Shares Double on Novartis Deal at InvestorGuide.com .
